Combined activity of interleukin-1 alpha or TNF-alpha and doxorubicin on multidrug resistant cell lines: evidence that TNF and DXR have synergistic antitumor and differentiation-inducing effects. [electronic resource]
- Anticancer research
- 2643-8 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0250-7005
ATP Binding Cassette Transporter, Subfamily B, Member 1--biosynthesis Animals Cell Differentiation--drug effects Cell Division--drug effects Cell Line Daunorubicin--pharmacology Dose-Response Relationship, Drug Doxorubicin--pharmacology Drug Resistance, Multiple Drug Synergism Humans Interleukin-1--pharmacology Leukemia, Erythroblastic, Acute Melanoma, Experimental Mice Tumor Cells, Cultured Tumor Necrosis Factor-alpha--pharmacology